‘Left wondering’

This rapid response by Shirley Nurock was made in response to a BMJ report that the US drug company Biogen is “walking away from its Alzheimer’s drug aducanumab (Aduhelm).” In … Continue reading ‘Left wondering’

Multiple adverse outcomes

This Research was published in the BMJ on the 17 April 2024 and has been made open access. The paper begins with this summary box: A decade has passed since … Continue reading Multiple adverse outcomes